Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi Wen

Showing results (671-680 of 692) with videos related to

Pageof 70
Sort By:
Genome Biology|May 22, 2015
Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplificationCharlotte K Y Ng, Luciano G Martelotto, Arnaud Gauthier, et al.
Scientific Reports|April 1, 2021
Genetic co-expression networks contribute to creating predictive model and exploring novel biomarkers for the prognosis of breast cancerYuan-Kuei Li, Huan-Ming Hsu, Meng-Chiung Lin, et al.
The Journal of Allergy and Clinical Immunology|August 20, 2018
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumabPatrick M Brunner, Ana B Pavel, Saakshi Khattri, et al.
Oncogene|May 1, 2018
Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathwayJer-Wei Chang, Wen-Hung Kuo, Chiao-Mei Lin, et al.
Frontiers in Surgery|September 19, 2022
Surgical outcome predictor analysis following hand-assisted or pure laparoscopic transperitoneal nephroureterectomy using the Taiwan upper urinary tract urothelial carcinoma databaseChih-Chun Kuo, Guang-Heng Chen, Chao-Hsiang Chang, et al.
Journal of Personalized Medicine|February 25, 2022
Clinical Efficacy of Adjuvant Chemotherapy in Advanced Upper Tract Urothelial Carcinoma (pT3-T4): Real-World Data from the Taiwan Upper Tract Urothelial Carcinoma Collaboration GroupChung-Yu Lin, Han-Yu Weng, Ta-Yao Tai, et al.
Frontiers in Oncology|June 20, 2022
The Value of Preoperative Local Symptoms in Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Retrospective, Multicenter Cohort StudyHsin-Chih Yeh, Chao-Hsiang Chang, Jen-Kai Fang, et al.
Journal of Clinical Medicine|December 2, 2020
Prognostic Significance of Primary Tumor Location in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Retrospective, Multi-Center Cohort Study in TaiwanLian-Ching Yu, Chao-Hsiang Chang, Chi-Ping Huang, et al.
Frontiers in Oncology|October 21, 2021
Comparing Oncological Outcomes and Surgical Complications of Hand-Assisted, Laparoscopic and Robotic Nephroureterectomy for Upper Tract Urothelial CarcinomaChing-Chia Li, Chao-Hsiang Chang, Chi-Ping Huang, et al.
Frontiers in Oncology|May 16, 2022
Is Lymph Node Dissection Necessary During Radical Nephroureterectomy for Clinically Node-Negative Upper Tract Urothelial Carcinoma? A Multi-Institutional StudyHsiang-Ying Lee, Chao-Hsiang Chang, Chi-Ping Huang, et al.
Pageof 70

Showing results (671-680 of 692) with videos related to

Sort By:
Pageof 70
Genome Biology|May 22, 2015
Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplificationCharlotte K Y Ng, Luciano G Martelotto, Arnaud Gauthier, et al.
Scientific Reports|April 1, 2021
Genetic co-expression networks contribute to creating predictive model and exploring novel biomarkers for the prognosis of breast cancerYuan-Kuei Li, Huan-Ming Hsu, Meng-Chiung Lin, et al.
The Journal of Allergy and Clinical Immunology|August 20, 2018
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumabPatrick M Brunner, Ana B Pavel, Saakshi Khattri, et al.
Oncogene|May 1, 2018
Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathwayJer-Wei Chang, Wen-Hung Kuo, Chiao-Mei Lin, et al.
Frontiers in Surgery|September 19, 2022
Surgical outcome predictor analysis following hand-assisted or pure laparoscopic transperitoneal nephroureterectomy using the Taiwan upper urinary tract urothelial carcinoma databaseChih-Chun Kuo, Guang-Heng Chen, Chao-Hsiang Chang, et al.
Journal of Personalized Medicine|February 25, 2022
Clinical Efficacy of Adjuvant Chemotherapy in Advanced Upper Tract Urothelial Carcinoma (pT3-T4): Real-World Data from the Taiwan Upper Tract Urothelial Carcinoma Collaboration GroupChung-Yu Lin, Han-Yu Weng, Ta-Yao Tai, et al.
Frontiers in Oncology|June 20, 2022
The Value of Preoperative Local Symptoms in Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Retrospective, Multicenter Cohort StudyHsin-Chih Yeh, Chao-Hsiang Chang, Jen-Kai Fang, et al.
Journal of Clinical Medicine|December 2, 2020
Prognostic Significance of Primary Tumor Location in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Retrospective, Multi-Center Cohort Study in TaiwanLian-Ching Yu, Chao-Hsiang Chang, Chi-Ping Huang, et al.
Frontiers in Oncology|October 21, 2021
Comparing Oncological Outcomes and Surgical Complications of Hand-Assisted, Laparoscopic and Robotic Nephroureterectomy for Upper Tract Urothelial CarcinomaChing-Chia Li, Chao-Hsiang Chang, Chi-Ping Huang, et al.
Frontiers in Oncology|May 16, 2022
Is Lymph Node Dissection Necessary During Radical Nephroureterectomy for Clinically Node-Negative Upper Tract Urothelial Carcinoma? A Multi-Institutional StudyHsiang-Ying Lee, Chao-Hsiang Chang, Chi-Ping Huang, et al.
Pageof 70